Showing results (1231-1240 of 1,456) with videos related to

Sort By:
Pageof 146
Food Technology and Biotechnology|July 17, 2023
Thymol-Loaded Polymeric Nanoparticles Improve the Postharvest Microbiological Safety of BlueberriesSyarifah Ab Rashid, Woei-Yenn Tong, Chean-Ring Leong, et al.
British Journal of Haematology|December 1, 1996
Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT)N Schmitz, A Bacigalupo, M Labopin, et al.
American Journal of Physiology. Renal Physiology|August 21, 2009
Novel missense mutation of uromodulin in mice causes renal dysfunction with alterations in urea handling, energy, and bone metabolismElisabeth Kemter, Birgit Rathkolb, Jan Rozman, et al.
Scientific Reports|February 26, 2020
Homalomena pineodora essential oil nanoparticle inhibits diabetic wound pathogensNur Amiera Syuhada Rozman, Woei Yenn Tong, Chean Ring Leong, et al.
Genome Announcements|September 26, 2015
Near-Complete Genome Sequence of the Cellulolytic Bacterium Bacteroides (Pseudobacteroides) cellulosolvens ATCC 35603Bareket Dassa, Sagar Utturkar, Richard A Hurt, et al.
Journal of Palliative Medicine|February 3, 2021
Rapid Transition to Virtual Care during the COVID-19 Epidemic: Experience of a Supportive Care Clinic at a Tertiary Care Cancer CenterAkhila Reddy, Joseph Arthur, Shalini Dalal, et al.
Science (New York, N.Y.)|May 8, 2010
Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytesAlexandros Vegiopoulos, Karin Müller-Decker, Daniela Strzoda, et al.
Annals of the Rheumatic Diseases|April 15, 2004
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisC-S Yee, C Gordon, C Dostal, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2009
Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotionJ Khasawneh, M D Schulz, A Walch, et al.
Annals of the Rheumatic Diseases|July 10, 2004
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritisJ van Holten, K Pavelka, J Vencovsky, et al.
Pageof 146